Clinical trial NCT00000487 - References

Cardiovascular Diseases — Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)

Citation(s)

•   Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial
  Multiple Risk Factor Intervention Trial Research Group. Am J Cardiol. 1985 Jan 1;55(1):1-15.
•   Benfari RC, McIntyre K, Eaker E, Blumberg S, Paul O
  The psychological effects of differential treatment of a high risk sample in a randomized clinical trial. Am J Public Health. 1979 Oct;69(10):996-1000.
•   Benfari RC, Sherwin R
  The multiple risk factor intervention trial after 4 years: a summing-up. Prev Med. 1981 Jul;10(4):544-6.
•   Benfari RC
  The multiple risk factor intervention trial (MRFIT). III. The model for intervention. Prev Med. 1981 Jul;10(4):426-42.
•   Blair SN, Shaten J, Brownell K, Collins G, Lissner L
  Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. Ann Intern Med. 1993 Oct 1;119(7 Pt 2):749-57.
•   Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ
  Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997 Dec 17;278(23):2069-74.
•   Caggiula AW, Christakis G, Farrand M, Hulley SB, Johnson R, Lasser NL, Stamler J, Widdowson G
  The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids. Prev Med. 1981 Jul;10(4):443-75.
•   Cauley JA, Gutai JP, Kuller LH, Dai WS
  Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol. 1987 Oct 1;60(10):771-7.
•   Cohen JD, Neaton JD, Prineas RJ, Daniels KA
  Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1987 Sep 1;60(7):548-54.
•   Connett JE, Kuller LH, Kjelsberg MO, Polk BF, Collins G, Rider A, Hulley SB
  Relationship between carotenoids and cancer. The Multiple Risk Factor Intervention Trial (MRFIT) Study. Cancer. 1989 Jul 1;64(1):126-34.
•   Connett JE, Stamler J
  Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial. Am Heart J. 1984 Sep;108(3 Pt 2):839-48.
•   Cooper GR, Haff AC, Widdowson GM, Bartsch GE, DuChene AG, Hulley SB
  Quality control in the MRFIT local screening and clinic laboratory. Control Clin Trials. 1986 Sep;7(3 Suppl):158S-65S.
•   Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial
  Multiple Risk Factor Intervention Trial Research Group. Am J Cardiol. 1986 Jul 1;58(1):1-13.
•   Coughlin SS, Neaton JD, Sengupta A, Kuller LH
  Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1994 Jan 15;139(2):166-72.
•   Coughlin SS, Neaton JD, Sengupta A
  Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996 May 15;143(10):1002-6.
•   Crow RS, Prineas RJ, Hannan PJ, Grandits G, Blackburn H
  Prognostic associations of Minnesota Code serial electrocardiographic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1997 Jul 15;80(2):138-44.
•   Crow RS, Rautaharju PM, Prineas RJ, Connett JE, Furberg C, Broste S, Stamler J
  Risk factors, exercise fitness and electrocardiographic response to exercise in 12,866 men at high risk of symptomatic coronary heart disease. Am J Cardiol. 1986 May 1;57(13):1075-82.
•   Cutler JA, Grandits GA, Grimm RH Jr, Thomas HE Jr, Billings JH, Wright NH
  Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group. Prev Med. 1991 Mar;20(2):183-96.
•   Cutler JA, Neaton JD, Hulley SB, Kuller L, Paul O, Stamler J
  Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials. Prev Med. 1985 May;14(3):293-311.
•   Cutler JA, Stamler J
  Introduction and summary of the dietary and nutritional methods and findings in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):184S-190S.
•   Daniel-Gentry J, Dolecek TA, Caggiula AW, Van Horn LV, Epley L, Randall BL
  Increasing the use of meatless meals: a nutrition intervention substudy in the Multiple Risk Factor Intervention Trial (MRFIT). J Am Diet Assoc. 1986 Jun;86(6):778-81.
•   Davey Smith G, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH; Multiple Risk Factor Intervention Trial Research Group
  Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Ann Intern Med. 2005 Mar 1;142(5):313-22.
•   Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J
  Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet. 1998 Mar 28;351(9107):934-9.
•   Dennis B, Ernst N, Hjortland M, Tillotson J, Grambsch V
  The NHLBI nutrition data system. J Am Diet Assoc. 1980 Dec;77(6):641-7.
•   Dischinger P, DuChene AG
  Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986 Sep;7(3 Suppl):137S-57S.
•   Dolecek TA, Granditis G
  Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet. 1991;66:205-16.
•   Dolecek TA, Johnson RL, Grandits GA, Farrand-Zukel M, Caggiula AW
  Nutritional adequacy of diets reported at baseline and during trial years 1-6 by the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):305S-313S.
•   Dolecek TA, Milas NC, Van Horn LV, Farrand ME, Gorder DD, Duchene AG, Dyer JR, Stone PA, Randall BL
  A long-term nutrition intervention experience: lipid responses and dietary adherence patterns in the Multiple Risk Factor Intervention Trial. J Am Diet Assoc. 1986 Jun;86(6):752-8.
•   Dolecek TA, Stamler J, Caggiula AW, Tillotson JL, Buzzard IM
  Methods of dietary and nutritional assessment and intervention and other methods in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):196S-210S.
•   DuChene AG, Hultgren DH, Neaton JD, Grambsch PV, Broste SK, Aus BM, Rasmussen WL
  Forms control and error detection procedures used at the Coordinating Center of the Multiple Risk Factor Intervention Trial (MRFIT). Control Clin Trials. 1986 Sep;7(3 Suppl):34S-45S.
•   Evans RW, Shaten BJ, Day BW, Kuller LH
  Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1998 Jan 15;147(2):180-6. Review.
•   Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LH; MRFIT Research Group
  Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial. Indian Heart J. 2000 Nov-Dec;52(7 Suppl):S44-52.
•   Evans RW, Shpilberg O, Shaten BJ, Ali S, Kamboh MI, Kuller LH
  Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial. J Clin Epidemiol. 2001 Jan;54(1):51-7.
•   Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial
  Multiple Risk Factor Intervention Trial Research Group. Am J Cardiol. 1985 Jan 1;55(1):16-24.
•   Farrand ME, Mojonnier L
  Nutrition in the Multiple Risk Factor Intervention Trial (MRFIT). J Am Diet Assoc. 1980 Apr;76(4):347-51.
•   Flack JM, Neaton J, Grimm R Jr, Shih J, Cutler J, Ensrud K, MacMahon S
  Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation. 1995 Nov 1;92(9):2437-45.
•   Flack JM, Neaton JD, Daniels B, Esunge P
  Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis. 1993 Apr;21(4 Suppl 1):31-40.
•   Folsom AR, Hughes JR, Buehler JF, Mittelmark MB, Jacobs DR Jr, Grimm RH Jr
  Do type A men drink more frequently than type B men? Findings in the Multiple Risk Factor Intervention Trial (MRFIT). J Behav Med. 1985 Sep;8(3):227-35.
•   Friedewald WT, Kuller LH, Ockene JK
  Primary prevention of cancer: relevant Multiple Risk Factor Intervention Trial results. IARC Sci Publ. 1990;(103):157-70.
•   Gerace TA, Hollis J, Ockene JK, Svendsen K
  Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group. Prev Med. 1991 Sep;20(5):602-20.
•   Gorder DD, Bartsch GE, Tillotson JL, Grandits GA, Stamler J
  Food group and macronutrient intakes, trial years 1-6, in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):258S-271S.
•   Gorder DD, Dolecek TA, Coleman GG, Tillotson JL, Brown HB, Lenz-Litzow K, Bartsch GE, Grandits G
  Dietary intake in the Multiple Risk Factor Intervention Trial (MRFIT): nutrient and food group changes over 6 years. J Am Diet Assoc. 1986 Jun;86(6):744-51.
•   Grandits GA, Bartsch GE, Stamler J
  Method issues in dietary data analyses in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):211S-227S.
•   Grimm RH Jr, Cohen JD, Smith WM, Falvo-Gerard L, Neaton JD
  Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups. Arch Intern Med. 1985 Jul;145(7):1191-9.
•   Grimm RH Jr, Neaton JD, Ludwig W
  Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985 Oct 11;254(14):1932-7.
•   Grimm RH Jr, Neaton JD, McDonald M, Case J, McGill E, Allen R, Bailey-Hoffman G, Kousch D, Childs J, Hulley SB
  Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: a randomized study within a clinical trial. Am Heart J. 1985 Apr;109(4):858-64.
•   Grimm RH Jr, Tillinghast S, Daniels K, Neaton JD, Mascioli S, Crow R, Pritzker M, Prineas RJ
  Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation. 1987 Mar;75(3 Pt 2):II6-8.
•   Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L
  Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996 May 1;143(9):889-97.
•   Harrison HH, Morgan J
  Quality control of screening procedures in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986 Sep;7(3 Suppl):91S-108S.
•   Hollis JF, Connett JE, Stevens VJ, Greenlick MR
  Stressful life events, Type A behavior, and the prediction of cardiovascular and total mortality over six years. MRFIT Group. J Behav Med. 1990 Jun;13(3):263-80.
•   Hughes GH, Hymowitz N, Ockene JK, Simon N, Vogt TM
  The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking. Prev Med. 1981 Jul;10(4):476-500.
•   Hulley S, Ashman P, Kuller L, Lasser N, Sherwin R
  HDL-cholesterol levels in the Multiple Risk Factor Intervention Trial (MRFIT) by the MRFIT Research Group 1,2. Lipids. 1979 Jan;14(1):119-123.
•   Hymowitz N, Sexton M, Ockene J, Grandits G
  Baseline factors associated with smoking cessation and relapse. MRFIT Research Group. Prev Med. 1991 Sep;20(5):590-601.
•   Hymowitz N: The Multiple Risk Factor Intervention Trial: A Four Year Evaluation
  Int J Ment Health, 11:44-67, 1982.
•   Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD
  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989 Apr 6;320(14):904-10.
•   Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO
  Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J. 1986 Oct;112(4):825-36.
•   Kirkpatrick K
  Clinic operation: quality control of data collection and follow-up procedures. Control Clin Trials. 1986 Sep;7(3 Suppl):109S-25S.
•   Kjelsberg MO, Cutler JA, Dolecek TA
  Brief description of the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):191S-195S.
•   Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J
  End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997 Apr 23-30;277(16):1293-8.
•   Kuller L, Farrier N, Caggiula A, Borhani N, Dunkle S
  Relationship of diuretic therapy and serum magnesium levels among participants in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1985 Dec;122(6):1045-59.
•   Kuller L, Neaton J, Caggiula A, Falvo-Gerard L
  Primary prevention of heart attacks: the multiple risk factor intervention trial. Am J Epidemiol. 1980 Aug;112(2):185-99.
•   Kuller L: Risk Factor Reduction in CHD
  Modern Concepts of Cardiovascular Disease, 53:7-11, 1984.
•   Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Tracy RP
  The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1991 Dec 1;134(11):1266-77.
•   Kuller LH, Hulley SB, Cohen JD, Neaton J
  Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis. Circulation. 1986 Jan;73(1):114-23.
•   Kuller LH, Ockene J, Meilahn E, Svendsen KH
  Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Epidemiol. 1990 Aug;132(2):265-74.
•   Kuller LH, Ockene JK, Meilahn E, Wentworth DN, Svendsen KH, Neaton JD
  Cigarette smoking and mortality. MRFIT Research Group. Prev Med. 1991 Sep;20(5):638-54.
•   Kuller LH, Ockene JK, Townsend M, Browner W, Meilahn E, Wentworth DN
  The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. Am Rev Respir Dis. 1989 Sep;140(3 Pt 2):S76-81.
•   Kuller LH, Tracy RP, Shaten J, Meilahn EN
  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996 Sep 15;144(6):537-47.
•   Lasser NL, Grandits G, Caggiula AW, Cutler JA, Grimm RH Jr, Kuller LH, Sherwin RW, Stamler J
  Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Am J Med. 1984 Feb 27;76(2A):52-66.
•   Lasser NL, Lamb S, Dischinger P, Kirkpatrick K
  Background and organization of quality control in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986 Sep;7(3 Suppl):1S-16S.
•   Leon AS, Connett J, Jacobs DR Jr, Rauramaa R
  Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial. JAMA. 1987 Nov 6;258(17):2388-95.
•   Leon AS, Connett J, Jacobs DR, et al: Relation of Leisure Time Physical Activity to Mortality in the Multiple Risk Factor Intervention Trial
  Circulation, 70 (Suppl 2) II-644, 1984.
•   Leon AS, Connett J
  Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol. 1991 Sep;20(3):690-7.
•   Leon AS, Myers MJ, Connett J
  Leisure time physical activity and the 16-year risks of mortality from coronary heart disease and all-causes in the Multiple Risk Factor Intervention Trial (MRFIT). Int J Sports Med. 1997 Jul;18 Suppl 3:S208-15.
•   MacMahon S, Collins G, Rautaharju P, Cutler J, Neaton J, Prineas R, Crow R, Stamler J
  Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1989 Jan 15;63(3):202-10.
•   Mandriota R, Bunkers B, Wilcox ME
  Nutrition intervention strategies in the Multiple Risk Factor Intervention Trial (MRFIT). J Am Diet Assoc. 1980 Aug;77(2):138-40.
•   Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D
  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986 Oct 25;2(8513):933-6.
•   Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial
  Circulation. 1990 Nov;82(5):1616-28.
•   Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial
  Circulation. 1996 Sep 1;94(5):946-51. Erratum in: Circulation 1997 Feb 4;95(3):760.
•   Mortality rates after 10
  5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group. JAMA. 1990 Apr 4;263(13):1795-801. Erratum in: JAMA 1990 Jun 20;263(23):3151.
•   Multiple Risk Factor Intervention Trial Group: Multiple Risk Factor Intervention Trial
  Proceedings of the Nutrition Behavioral Research Conference. NHLBI, NIH, DHEW Publication No. (NIH) 76-978, p. ll, l975.
•   Multiple Risk Factor Intervention Trial Group: Public Annual Report, Multiple Risk Factor Intervention Trial, June 30, l974 to July l, l975
  U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, DHEW Publication No. (NIH) 76-l000, August, l975.
•   Multiple Risk Factor Intervention Trial Group: Public Annual Report, Multiple Risk Factor Intervention Trial, June 30, l975 to July l, l976
  U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, DHEW Publication No. (NIH) 77-l2ll, August, l976.
•   Multiple Risk Factor Intervention Trial Group: Smoking Cessation Activities in the Multiple Risk Factor Intervention Trial: A Preliminary Report
  J. Steinfeld et al (Eds). Smoking & Health: Proceedings of the Third World Conference on Smoking and Health, June 2-5, l975, II Health Consequences, Education, Cessation Activities, and Social Action, U.S. Government Printing Office, Washington, D.C., l976, 6l3-6l7.
•   Multiple risk factor intervention trial
  Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA. 1982 Sep 24;248(12):1465-77.
•   Neaton JD, Bartsch GE, Broste SK, Cohen JD, Simon NM
  A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group. Control Clin Trials. 1991 Dec;12(6):731-40.
•   Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D
  Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992 Jul;152(7):1490-500.
•   Neaton JD, Broste S, Cohen L, Fishman EL, Kjelsberg MO, Schoenberger J
  The multiple risk factor intervention trial (MRFIT). VII. A comparison of risk factor changes between the two study groups. Prev Med. 1981 Jul;10(4):519-43.
•   Neaton JD, Grimm RH Jr, Cutler JA
  Recruitment of participants for the multiple risk factor intervention trial (MRFIT). Control Clin Trials. 1987 Dec;8(4 Suppl):41S-53S.
•   Neaton JD, Kuller L, Stamler J, Wentworth D
  Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd Ed. New York: Raven Press,Ltd., 1995:127-144.
•   Neaton JD, Kuller LH, Wentworth D, Borhani NO
  Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J. 1984 Sep;108(3 Pt 2):759-69.
•   Neaton JD, Wentworth D
  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992 Jan;152(1):56-64.
•   Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L
  Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol. 1993 Sep;3(5):493-9.
•   Ockene J: Multiple Risk Factor Intervention Trial: Smoking Cessation Procedures and Cessation Patterns for a Large Cohort of MRFIT Participants
  In Schwartz J (Ed): Progress in Smoking Cessation, American Cancer Society, New York, p. 183-198, 1979.
•   Ockene JK, Hulley SB, Gerace TA: Smoking Behavior Change Patterns in the Multiple Risk Factor Intervention Trials (MRFIT) and Their Relationship to Mortality from Coronary Heart Disease (CHD)
  Proceedings of the Fifth World Conference on Smoking and Health, Winnipeg, Canada, 1983 403-414, (Jan 1986).
•   Ockene JK, Hymowitz N, Lagus J, Shaten BJ
  Comparison of smoking behavior change for SI and UC study groups. MRFIT Research Group. Prev Med. 1991 Sep;20(5):564-73.
•   Ockene JK, Hymowitz N, Sexton M, Broste SK
  Comparison of patterns of smoking behavior change among smokers in the Multiple Risk Factor Intervention Trial (MRFIT). Prev Med. 1982 Nov;11(6):621-38.
•   Ockene JK, Kuller LH, Svendsen KH, Meilahn E
  The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health. 1990 Aug;80(8):954-8.
•   Ockene JK, Pechacek TF, Vogt T, Svendsen K
  Does switching from cigarettes to pipes or cigars reduce tobacco smoke exposure? Am J Public Health. 1987 Nov;77(11):1412-6.
•   Ockene JK, Shaten BJ
  Cigarette smoking in the Multiple Risk Factor Intervention Trial (MRFIT). Introduction, overview, method, and conclusions. Prev Med. 1991 Sep;20(5):552-63.
•   Okin PM, Grandits G, Rautaharju PM, Prineas RJ, Cohen JD, Crow RS, Kligfield P
  Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial. J Am Coll Cardiol. 1996 May;27(6):1437-43.
•   Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA
  Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol. 1994 Jan;4(1):40-5.
•   Rautaharju PM, Broste SK, Prineas RJ, Eifler WJ, Crow RS, Furberg CD
  Quality control procedures for the resting electrocardiogram in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986 Sep;7(3 Suppl):46S-65S.
•   Rautaharju PM, Prineas RJ, Crow RS, Seale D, Furberg C
  The effect of modified limb electrode positions on electrocardiographic wave amplitudes. J Electrocardiol. 1980 Apr;13(2):109-13.
•   Rautaharju PM, Prineas RJ, Eifler WJ, Furberg CD, Neaton JD, Crow RS, Stamler J, Cutler JA
  Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol. 1986 Jul;8(1):1-10.
•   Rautaharju PM, Seale D, Prineas R, Wolf H, Crow R, Warren J
  Changing electrocardiographic recording technology and diagnostic accuracy of myocardial infarction criteria. Improved standards for evaluation of ECG measurement precision. J Electrocardiol. 1978 Oct;11(4):321-30.
•   Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial
  Multiple Risk Factor Intervention Trial Research Group. Prev Med. 1986 May;15(3):254-73.
•   Remmell PS, Benfari RC
  Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). II. Food record rating as an indicator of compliance. J Am Diet Assoc. 1980 Apr;76(4):357-60.
•   Remmell PS, Gorder DD, Hall Y, Tillotson JL
  Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). I. Use of a dietary monitoring tool. J Am Diet Assoc. 1980 Apr;76(4):351-6.
•   Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM
  Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988 Mar;77(3):504-14. Review.
•   Ruth KJ, Neaton JD
  Evaluation of two biological markers of tobacco exposure. MRFIT Research Group. Prev Med. 1991 Sep;20(5):574-89.
•   Scherwitz L, Graham LE 2nd, Grandits G, Billings J
  Speech characteristics and behavior-type assessment in the Multiple Risk Factor Intervention Trial (MRFIT) structured interviews. J Behav Med. 1987 Apr;10(2):173-95.
•   Scherwitz L, Graham LE 2nd, Grandits G, Buehler J, Billings J
  Self-involvement and coronary heart disease incidence in the multiple risk factor intervention trial. Psychosom Med. 1986 Mar-Apr;48(3-4):187-99.
•   Schoenenberger JC
  Smoking change in relation to changes in blood pressure, weight, and cholesterol. Prev Med. 1982 Jul;11(4):441-53.
•   Shaten BJ, Kuller LH, Kjelsberg MO, Stamler J, Ockene JK, Cutler JA, Cohen JD
  Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial. Ann Epidemiol. 1997 Feb;7(2):125-36.
•   Shaten BJ, Kuller LH, Neaton JD
  Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med. 1991 Sep;20(5):655-9.
•   Shaten BJ, Smith GD, Kuller LH, Neaton JD
  Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Oct;16(10):1331-9.
•   Shekelle R: Diuretic Treatment of Hypertension and Changes in Plasma Lipids Over Six Years in the Multiple Risk Factor Intervention Trial
  In Paoletti R, et al (Eds): Endpoints for Cardiovascular Drug Studies. New York, Raven, p. 216, 1984.
•   Shekelle RB, Caggiula AW, Grimm RH: Diuretic Treatment of Hypertension and Changes in Plasma Lipids Over Six Years in the Multiple Risk Factor Intervention Trial
  In Hegyeli RJ (Ed): Atherosclerosis Review. New York, Raven, p. 113-127, 1984.
•   Shekelle RB, Hulley SB, Neaton JD, Billings JH, Borhani NO, Gerace TA, Jacobs DR, Lasser NL, Mittlemark MB, Stamler J
  The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease. Am J Epidemiol. 1985 Oct;122(4):559-70.
•   Sherwin R, Kaelber CT, Kezdi P, Kjelsberg MO, Thomas HE Jr
  The multiple risk factor intervention trial (MRFIT) II. The development of the protocol. Prev Med. 1981 Jul;10(4):402-25.
•   Sherwin R, Sengupta A, Havas S
  Blood pressure in minorities screened for the Multiple Risk Factor Intervention Trial (MRFIT). Public Health Rep. 1996;111 Suppl 2:68-70.
•   Sherwin R
  Sudden death in men with increased risk of myocardial infarction. The MRFIT Programme. Drugs. 1984 Oct;28 Suppl 1:46-53.
•   Sherwin R: Diuretics, Serum Potassium and Mortality in the Multiple Risk Factor Intervention Trial (MRFIT)
  In Whelton T, et al (Eds): Potassium in Cardiovascular and Renal Medicine, New York, Marcelle Decker, 293-303, 1986.
•   Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J
  Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA. 1987 Feb 20;257(7):943-8.
•   Simon JA, Fong J, Bernert JT Jr, Browner WS
  Serum fatty acids and the risk of fatal cancer. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1998 Nov 1;148(9):854-8.
•   Stamler J, Briefel RR, Milas C, Grandits GA, Caggiula AW
  Relation of changes in dietary lipids and weight, trial years 1-6, to changes in blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):272S-288S.
•   Stamler J, Caggiula A, Grandits GA, Kjelsberg M, Cutler JA
  Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT). Circulation. 1996 Nov 15;94(10):2417-23.
•   Stamler J, Caggiula AW, Grandits GA
  Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):338S-365S.
•   Stamler J, Dolecek TA
  Relation of food and nutrient intakes to body mass in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):366S-373S.
•   Stamler J, Paul O, Berkson DM, et al: The New National Cooperative Multiple Risk Factor Intervention Trial (Heart Attack Prevention Program)
  Chicago Medicine, 76:1047-1048, 1973.
•   Stamler J, Rains-Clearman D, Lenz-Litzow K, Tillotson JL, Grandits GA
  Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):374S-402S.
•   Stamler J, Vaccaro O, Neaton JD, Wentworth D
  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Feb;16(2):434-44.
•   Stamler J, Wentworth D, Neaton JD
  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986 Nov 28;256(20):2823-8.
•   Stamler J, Wentworth D, Neaton JD
  Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial. Am J Med. 1986 Feb 14;80(2A):33-9.
•   Stamler J: The Multiple Risk Factor Intervention Trial (MRFIT)
  In Hoffman H (Ed): Primary and Secondary Prevention of Coronary Heart Disease. Berlin, Heidelberg, Springer-Verlag, 8-33, 1985.
•   Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT)
  The Multiple Risk Factor Intervention Trial Group. J Chronic Dis. 1977 May;30(5):261-75.
•   Suh I, Shaten BJ, Cutler JA, Kuller LH
  Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med. 1992 Jun 1;116(11):881-7.
•   Svendsen KH, Kuller LH, Martin MJ, Ockene JK
  Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1987 Nov;126(5):783-95.
•   The MRFIT behavior pattern study--I
  Study design, procedures, and reproducibility of behavior pattern judgments. The Multiple Risk Factor Intervention Trial Group. J Chronic Dis. 1979;32(4):293-305.
•   The multiple risk factor intervention trial (MRFIT)
  A national study of primary prevention of coronary heart disease. JAMA. 1976 Feb 23;235(8):825-7.
•   The multiple risk factor intervention trial
  The Multiple Risk Factor Intervention Trial Group. Ann N Y Acad Sci. 1978 Mar 30;304:293-308.
•   Tillotson JL, Bartsch GE, Gorder D, Grandits GA, Stamler J
  Food group and nutrient intakes at baseline in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):228S-257S.
•   Tillotson JL, Gorder DD, DuChene AG, Grambsch PV, Wenz J
  Quality control in the Multiple Risk Factor Intervention Trial Nutrition Modality. Control Clin Trials. 1986 Sep;7(3 Suppl):66S-90S.
•   Tillotson JL, Gorder DD, Kassim N
  Nutrition data collection in the Multiple Risk Factor Intervention Trial (MRFIT). Baseline nutrient intake of a randomized population. J Am Diet Assoc. 1981 Mar;78(3):235-40.
•   Tillotson JL, Grandits GA, Bartsch GE, Stamler J
  Relation of dietary carbohydrates to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):314S-326S.
•   Tillotson JL, Grandits GA, Bartsch GE, Stamler J
  Relation of dietary fiber to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):327S-337S.
•   Townsend MC, DuChene AG, Morgan J, Browner WS
  Pulmonary function in relation to cigarette smoking and smoking cessation. MRFIT Research Group. Prev Med. 1991 Sep;20(5):621-37.
•   Townsend MC, Morgan J, Durkin D, DuChene AG, Lamb S
  Quality control aspects of pulmonary function testing in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986 Sep;7(3 Suppl):179S-92S.
•   Vaccaro O, Stamler J, Neaton JD
  Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol. 1998 Aug;27(4):636-41.
•   Van Horn L, Dolecek TA, Grandits GA, Skweres L
  Adherence to dietary recommendations in the special intervention group in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr. 1997 Jan;65(1 Suppl):289S-304S.
•   Watkins LO, Neaton JD, Kuller LH
  Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1986 Mar 1;57(8):538-45.
•   Wentworth DN, Neaton JD, Rasmussen WL
  An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health. 1983 Nov;73(11):1270-4.
•   Werkö L
  Analysis of the MRFIT screenees: a methodological study. J Intern Med. 1995 May;237(5):507-18.
•   Widdowson GM, Kuehneman M, DuChene AG, Hulley SB, Cooper GR
  Quality control of biochemical data in the Multiple Risk Factor Intervention Trial: Central Laboratory. Control Clin Trials. 1986 Sep;7(3 Suppl):17S-33S.
•   Zhou SH, Rautaharju PM, Prineas R, Neaton J, Crow R, Calhoun H, Furberg C, Cohen J
  Improved ECG models for estimation of left ventricular hypertrophy progression and regression incidence by redefinition of the criteria for a significant change in left ventricular hypertrophy status. The MRFIT Research Group. Multiple Risk Factor Intervention Trial. J Electrocardiol. 1993;26 Suppl:108-13.
•   Zukel WJ, Paul O, Schnaper HW
  The multiple risk factor intervention trial (MRFIT). I. Historical perspective. Prev Med. 1981 Jul;10(4):387-401.

Details for clinical trial NCT00000487